JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma

Overview of attention for article published in Science, June 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 15 news outlets
blogs: 2 blogs
twitter: 73 X users

facebook: 3 Facebook pages
wikipedia: 1 Wikipedia page
reddit: 2 Redditors

Readers on

mendeley: 119 Mendeley

So far, Altmetric has seen 74 X posts from 73 X users, with an upper bound of 1,507,532 followers.

#Highlight Paper in #MedComm Combining JAK Inhibitors with Immune Checkpoint Inhibitors: Overcoming Resistance in Cancer Treatment Authored by Prof. Haijing Zhong @JinanUniversity Learn more https://t.co/Y849kvT3NH The highlighted article in @Science …

RT @ScienceMagazine: In two separate Science studies, researchers report that combining JAK inhibitors with checkpoint inhibitor immunother…

②ICI使用時のJAKi併用はmyeloid細胞の抑制により抗腫瘍効果を向上させる可能性がある。今後RA患者のICI使用時はJAKiが優先されるかも。 https://t.co/lrC4q33THH

RT @AlcazerVincent: JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma | Science https://t.co/QUeS…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 70 additional X posts.